🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Curious about the 𝗔𝗥𝗢𝗡 𝗽𝗿𝗼𝗷𝗲𝗰𝘁? 🎥Watch the video and see how we're shaping tomorrow. Let us know your thoughts below👇

Out now on European Urology Oncology the first ARON-3 manuscript by ARON project about the global real world of apalutamide in mHSPC Thanks to Matteo Santoni pas_rescigno Andrey Soares and all Aron Team! Università di Bologna AIOM

Fantastic presentation today about neoadjuvant tretaments for urothelial cancer by veronica mollica at the first masterclass on robot-assisted radical cystectomy and neobladder

10,000 patients worldwide! 🌍 We’ve reached a major milestone thanks to the incredible dedication of our global network. Thank you all! ❤️ #AronProject #10k #GlobalCollaboration

📢 State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes ⚠️ Out now by Elisa Tassinari and Linda Danielli, two rising stars of GU Team in Bologna veronica mollica Università di Bologna tandfonline.com/doi/full/10.10…

📆 On 17-18 January 2025 we will host the first edition of the Florence Multidisciplinary Expert Meeting on Renal Cell Carcinoma. Scientific Program 👉tinyurl.com/5n7h469s 🎬The meeting has been designed by the Azienda Ospedaliero-Universitaria Careggi Urologic Multidisciplinary Tumor Board to allow a

Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma. Out now on Cancer Treatment Reviews. Special Thanks to Sumanta K. Pal, MD, FASCO for the precious support. ESMO - Eur. Oncology Matteo Santoni veronica mollica Kidney Cancer AIOM

Day 2 of Florence Multidisciplinary Expert Meeting on RCC kicked off with an emotional and thought-provoking lecture by Riccardo Campi , highlighting the spirit of collaboration, friendship, and innovation that defines the EAU-YAU Renal Cancer Working Group in advancing RCC care!

Stellar presentation by veronica mollica at the Florence Multidisciplinary Expert Meeting on RCC. Thanks also to Riccardo Campi for the invitation to this fantastic meeting.

Our first Florence Multidisciplinary Expert Meeting on RCC Long story short: 2 days full of #science & #emotions, surrounded by experts and brilliant researchers in the field, all part of a wonderful #family aiming to share knowledge and expertise to advance #RCC care. Embraced by the beauty of Florence.

Role of Hb to RDW ratio in metastatic RCC patients treated with first-line immunotherapy combinations. A promising prognostic factor for better patient counselling and treatment decisions. 🔗 Read more: doi.org/10.1080/175074… #RenalCancer #Immunotherapy #Research

Another important paper by ARON project

YAU RCC Brainstorming session at #EAU25

Beyond research, it’s the human bond that makes a team truly strong 💪 Dinner night for the YAU RCC family in Madrid 🇪🇸 EAU Young Urologists European Association of Urology (EAU) #EAU25

Join Kidney Cancer Europe 2025: pre-conference surgical workshop Cutting-Edge on kidney focused on local therapies for advanced RCC YAU RCC will be there contributing to the conversation 🗓️ May 1, 2025 – Amsterdam 📍 Register at kidneycancer.org

Great overview on #chromophobe today in Padua with Francesco Massari! 🧠🔬 Congrats to Marco Maruzzo group for the excellent work! 👏🏼🧪 UroFocus OncoDaily Over veronica mollica KidneyCAN Kidney Cancer IKCC Kidney Cancer Kidney Cancer Canada

Productive first meeting of the new YAU RCC team! Projects assigned, ideas flowing, collaborations set in motion💡🤝🏻 Ready to tackle the key challenges in RCC research — together 💪🏻 EAU Young Urologists European Association of Urology (EAU)

Urologic oncology represents absolute lowest ⬇️rate of female first/last publication among all oncology specialties here .. the % are embarrassing. ❗️Clearly a problem that’s why WUO is so incredibly important ascopubs.org/doi/full/10.12…

Thanks to Maite Bourlon for presenting ARON project at #ASCO2025 Oncoinfo OncoDaily ESMO - Eur. Oncology

🚨 New in European Urology Oncology: Is SBRT ready for primary RCC? With 5-year local control rates nearing 96%, it's a game-changer for inoperable cases—but the lack of final pathology may limit adjuvant therapy options. 🔗 Read the editorial: euoncology.europeanurology.com/article/S2588-… #UroOnc